In the SUSTAIN clinical trials, average weight loss with Ozempic 0.5 mg was approximately 34 kg, and with 1 mg approximately 46 kg over 612 months, though individual responses vary considerably
However, while there is a stronger stimulation of insulin secretion in response to GEP12 vs
In animal models, these compounds alleviated both acute pain and chronic pain induced by nerve injury
Patients in the HGSH group exhibited significantly higher recurrence rates, and mortality compared to the LGSH group
Measurable reductions in visceral fat on imaging typically become apparent by week 16 to 26
Unfortunately, the current trend is completely the opposite, with a steady increase in overweight and obesity affecting the youngest, putting them at very high risk of developing a veritable epidemic of cardiometabolic diseases in a few years (see our article on this subject)